FDA Clears Novo Nordisk’s Wegovy Weight-Loss Pill, Marking Major Shift in Obesity Drug Market
The U.S. Food and Drug Administration has approved Novo Nordisk’s oral weight-loss pill containing 25 milligrams of semaglutide, giving the Danish drugmaker a crucial first-mover advantage in the race to bring a potent obesity...